Europe Pharmacogenomics Market Includes Latest Trends, Share, and Forecast 2030

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

Europe

ESG Trends

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Products
  1. By Value
  2. Genotyping Kits
    1. Genotyping Kits By Value
  3. Sequencing Instruments
    1. Sequencing Instruments By Value
  4. PCR Reagents and Consumables
    1. PCR Reagents and Consumables By Value
  5. Sample Preparation Kits
    1. Sample Preparation Kits By Value
  6. Others
    1. Others By Value
3. Services
  1. By Value
  2. Genetic Testing Services
    1. Genetic Testing Services By Value
  3. Pharmacogenomic Consulting
    1. Pharmacogenomic Consulting By Value
  4. Others
    1. Others By Value
4. Software
  1. By Value
  2. Bioinformatics Software
    1. Bioinformatics Software By Value
  3. Clinical Decision Support System
    1. Clinical Decision Support System By Value
  4. Laboratory Information Management System
    1. Laboratory Information Management System By Value
  5. EHR Integration Software
    1. EHR Integration Software By Value
  6. Others
    1. Others By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Polymerase Chain Reaction
  1. By Value
4. Mass Spectrometry
  1. By Value
5. Microarray
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cardiovascular disease
  1. By Value
3. Infectious diseases
  1. By Value
4. Oncology
  1. By Value
5. Neurological diseases
  1. By Value
6. Pain Management and Trauma
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Clinical Laboratories
  1. By Value
4. Pharmaceutical Companies
  1. By Value
5. Academic Research Institutions
  1. By Value
6. Others
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Products
    1. By Value
    2. Genotyping Kits
      1. Genotyping Kits By Value
    3. Sequencing Instruments
      1. Sequencing Instruments By Value
    4. PCR Reagents and Consumables
      1. PCR Reagents and Consumables By Value
    5. Sample Preparation Kits
      1. Sample Preparation Kits By Value
    6. Others
      1. Others By Value
  3. Services
    1. By Value
    2. Genetic Testing Services
      1. Genetic Testing Services By Value
    3. Pharmacogenomic Consulting
      1. Pharmacogenomic Consulting By Value
    4. Others
      1. Others By Value
  4. Software
    1. By Value
    2. Bioinformatics Software
      1. Bioinformatics Software By Value
    3. Clinical Decision Support System
      1. Clinical Decision Support System By Value
    4. Laboratory Information Management System
      1. Laboratory Information Management System By Value
    5. EHR Integration Software
      1. EHR Integration Software By Value
    6. Others
      1. Others By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Polymerase Chain Reaction
    1. By Value
  4. Mass Spectrometry
    1. By Value
  5. Microarray
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Cardiovascular disease
    1. By Value
  3. Infectious diseases
    1. By Value
  4. Oncology
    1. By Value
  5. Neurological diseases
    1. By Value
  6. Pain Management and Trauma
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Clinical Laboratories
    1. By Value
  4. Pharmaceutical Companies
    1. By Value
  5. Academic Research Institutions
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europ

Competitive Landscape

Europe Pharmacogenomics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
HOFFMANN-LA ROCHE LTD.
Oxford Nanopore Technologies
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
QIAGEN
Agilent Technologies, Inc.
Myriad Genetics, Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment